Literature DB >> 34974711

The role of multidisciplinary teams in musculoskeletal infection.

Nike Walter1,2, Markus Rupp1, Susanne Baertl1, Volker Alt1.   

Abstract

Entities:  

Keywords:  Bone and joint infection; Fracture-related infection; Multidisciplinary treatment; Osteomyelitis; Periprosthetic joint infection; amputation of the affected limb; antibiotics; bone infection; fracture-related infection (FRI); infections; infectious disease; joint infection; musculoskeletal infection; orthopaedic and trauma surgery; orthopaedic surgeons

Year:  2022        PMID: 34974711      PMCID: PMC8801170          DOI: 10.1302/2046-3758.111.BJR-2021-0498

Source DB:  PubMed          Journal:  Bone Joint Res        ISSN: 2046-3758            Impact factor:   5.853


× No keyword cloud information.
Bone and joint infection (BJI) represents a major complication in orthopaedic and trauma surgery, with incidence rates of 24/100,000 inhabitants for periprosthetic joint infection (PJI), 17/100,000 inhabitants for osteomyelitis, and 11/100,000 inhabitants for fracture-related infection (FRI) in Germany. Steadily increasing primary arthroplasty procedures and numbers of fractures will further boost implant-associated infections. The choice of treatment is usually complex, depending on multiple factors such as soft-tissue and implant condition, duration of infection, the underlying pathogen, and the patient’s morbidity. Surgical strategies range from debridement of necrotic bone and implant retention in the case of stable implants and acute infection, to implant exchange in a one-stage, two-stage, or even multi-stage surgical treatment when infection is chronic or implants are loosened. Patients are faced with immobility up to amputation of the affected limb, pain, prolonged stay in hospital, the administration of local and systemic antibiotics with common side effects, and, consequently, reduced quality of life. Although classification systems and treatment algorithms have been developed, the uncertainty of surgeons regarding BJI treatment decision-making has been highlighted in a recent qualitative analysis. As the adequate treatment of BJI requires the consideration of multiple factors, case discussions between experts of different disciplines could enhance BJI management and research. Therefore, in order to achieve the best outcome for the patient, interdisciplinary approaches and early involvement of multidisciplinary teams are deemed important. Analogous to oncology, where interdisciplinary tumour boards have become an evidence-based gold standard in cancer therapy, collaborative approaches for the management of BJI should be supported. In addition, such interdisciplinary management complements the efforts of antibiotic stewardship programmes, and will play a key role in reducing the development of antimicrobial resistance. Going further, the establishment of a nationwide system with improved communication between centres specialized in treating BJI can also be beneficial as shown, for instance, in France. Ferguson et al recently investigated the impact of a multidisciplinary bone infection unit undertaking osteomyelitis surgery with a single-stage protocol on clinical outcomes and healthcare use. In comparison to national outcomes in England, the authors reported reduced hospital stays, lower reoperation rates for infection recurrence, improved survival, lower amputation rates, and lower overall healthcare use, advocating the establishment of centrally funded multidisciplinary bone infection units. A similar approach with valuable clinical experiences is reported by Carlson et al, with a collaboration between infectious disease clinicians and orthopaedic arthroplasty surgeons to optimize PJI treatment, which they termed “arthroplasty infection service”. Finally, Ntalos et al compared treatment outcomes of spondylodiscitis patients, whose treatment strategy was either established by a single discipline approach or by a weekly multidisciplinary infection conference consisting of orthopaedic surgeons, medical microbiologists, infectious disease specialists, and pathologists. The latter cohort showed reduced days of total antibiotic treatment, and the treatment plan differed between the groups. The same working group further demonstrated that patients treated for PJI of the hip had shorter in-hospital stay, reduced numbers of surgeries, and fewer antibiotics when discussed in a multidisciplinary setting. In addition, Bauer et al analyzed files of patients treated for bone and joint infection before and after the implementation of a multidisciplinary staff meeting, reporting optimized adaptation of antibiotic therapy. Furthermore, Kotsougiani-Fischer et al reported their experiences of multidisciplinary team meetings for patients with severe limb defects, concluding that such meetings represent a valid tool to tailor individualized treatment plans avoiding limb amputation. In conclusion, based on findings in the literature, interdisciplinary approaches should be implemented as a standard of patient care in trauma surgery to further improve clinical outcomes in the treatment of BJI, as is already common practice in oncology.
  23 in total

1.  Multidisciplinary team working in cancer: what is the evidence?

Authors:  Cath Taylor; Alastair J Munro; Rob Glynne-Jones; Clive Griffith; Paul Trevatt; Michael Richards; Amanda J Ramirez
Journal:  BMJ       Date:  2010-03-23

2.  Evaluation of an interdisciplinary therapy algorithm in patients with prosthetic joint infections.

Authors:  Matthias D Wimmer; Thomas M Randau; Sabine Petersdorf; Geert I Pagenstert; Markus Weißkopf; Dieter C Wirtz; Sascha Gravius
Journal:  Int Orthop       Date:  2013-07-13       Impact factor: 3.075

3.  Impact of a multidisciplinary staff meeting on the quality of antibiotherapy prescription for bone and joint infections in orthopedic surgery.

Authors:  S Bauer; M-A Bouldouyre; A Oufella; P Palmari; R Bakir; A Fabreguettes; H Gros
Journal:  Med Mal Infect       Date:  2012-10-30       Impact factor: 2.152

4.  Managing uncertainty - a qualitative study of surgeons' decision-making for one-stage and two-stage revision surgery for prosthetic hip joint infection.

Authors:  Andrew J Moore; Ashley W Blom; Michael R Whitehouse; Rachael Gooberman-Hill
Journal:  BMC Musculoskelet Disord       Date:  2017-04-12       Impact factor: 2.362

5.  Can the oncology classification system be used for prosthetic joint infection?: The PJI-TNM system.

Authors:  Volker Alt; Markus Rupp; Martin Langer; Florian Baumann; Andrej Trampuz
Journal:  Bone Joint Res       Date:  2020-05-16       Impact factor: 5.853

6.  Implementation of a multidisciplinary infections conference improves the treatment of spondylodiscitis.

Authors:  D Ntalos; B Schoof; D M Thiesen; L Viezens; H Kleinertz; H Rohde; A Both; A Luebke; A Strahl; M Dreimann; M Stangenberg
Journal:  Sci Rep       Date:  2021-05-04       Impact factor: 4.379

7.  [Prosthetic infections and the increasing importance of psychological comorbidities : An epidemiological analysis for Germany from 2009 through 2019].

Authors:  Nike Walter; Markus Rupp; Thilo Hinterberger; Volker Alt
Journal:  Orthopade       Date:  2021-03-09       Impact factor: 1.087

8.  Multidisciplinary team meetings for patients with complex extremity defects: a retrospective analysis of treatment recommendations and prognostic factors for non-implementation.

Authors:  Dimitra Kotsougiani-Fischer; Sebastian Fischer; Jan Warszawski; Paul A Gruetzner; Gregor Reiter; Christoph Hirche; Ulrich Kneser
Journal:  BMC Surg       Date:  2021-03-29       Impact factor: 2.102

9.  What is the burden of osteomyelitis in Germany? An analysis of inpatient data from 2008 through 2018.

Authors:  Nike Walter; Susanne Baertl; Volker Alt; Markus Rupp
Journal:  BMC Infect Dis       Date:  2021-06-10       Impact factor: 3.090

10.  The Value of Ortho-ID Teams in Treating Bone and Joint Infections.

Authors:  Shawn Vasoo; Monica Chan; Parham Sendi; Elie Berbari
Journal:  J Bone Jt Infect       Date:  2019-11-20
View more
  1 in total

1.  Effect of functional relaxation on the quality of life in patients with periprosthetic joint infection: Protocol for a randomised controlled trial.

Authors:  Nike Walter; Thomas Loew; Volker Alt; Markus Rupp
Journal:  BMJ Open       Date:  2022-10-17       Impact factor: 3.006

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.